Contact us
Young GI
Patients
Industry
Press
My Connect
Create myUEG account
About
To landing page
Who we are
Boards, Committees & Groups
Governance
Headquarters Management
History
What we do
Strategic Drivers
Year in Review
Our Members
Specialist Member Societies
National Member Societies
myUEG Community
myUEG Associates
My Connect
Women in GI
Young GIs
Researchers
Event Calendar
Week
To landing page
Programme
Postgraduate Teaching
Industry
Supporters
CME Accreditation
UEG Week on-demand
Future UEG Weeks
Education
To landing page
Online Education
Online Courses
Webinars
Career Development
Face-to-face Education
Summer School
Masterclass
Clinical Visiting Fellowships
Education Resources
Mistakes in...
UEG Talks Podcast
Image Hub
CME in Europe
Event Endorsement
Supporters
Research
To landing page
Support
Horizon Europe Support
Start-up Grant
Research Prize
Research Fellowship
Research Webinars
Research Projects
HoloSurge
Position Papers
White Book 2
Main Results
Full Reports
Materials and Presentations
Quality of Care
To landing page
Search Guidelines
Standards & Guidelines Repository
Non-English Guidelines
GI Guidelines App
Develop & Implement
How to develop guidelines
Guideline Endorsement
Guideline Webinars
Projects
Quality of Care Initiatives
Quality Standards
Public Affairs
To landing page
Advocacy
Core Positions
Stakeholder Collaboration
White Book 2
Position Papers
MEP Digestive Health Group
Our Supporters
#EUNewsline →
EU Elections 2024
Publications
To landing page
Publications
Congress Publications
Research Publications
Public Affairs Publications
Education Publications
UEG Publications
UEG Journal →
UEG Journal Podcast
White Book 2
Opportunities
To landing page
Congress Opportunities
Top Abstract Prizes
National Scholar Award
Travel Grants
International Scholarship Awards
Research Funding
Research Prize
Research Fellowship
Horizon Europe Support
Start-up Grant
Activities Funding
Recognition of Achievements
Lifetime Achievement Award
Journal Best Paper Award
Activities Endorsement
Professional Advancement
Rising Star Awards
Clinical Visiting Fellowships
Open Positions
Talent Pool
Library
To landing page
Congress Resources
UEG Week on-demand
Abstracts
Posters
Guideline Resources
Education Resources
Image Hub
Webinars
Mistakes in... articles
Contact us
Young GI
Patients
Industry
Press
Session
IBD (Posters)
ASSOCIATION OF SERUM VITAMIN D LEVELS WITH DRUG TROUGH CONCENTRATIONS AND ANTI-DRUG ANTIBODY LEVELS DURING INFLIXIMAB THERAPY IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
IMMUNE AND NON IMMUNE CHANGES FOLLOWING FMT IN EXPERIMENTAL COLITIS: EMERGING PATHWAYS OF FMT-DERIVED MUCOSAL HEALING
VEDOLIZUMAB SUBCUTANEOUSLY: REAL-WORLD DATA BEFORE AND AFTER SWITCH IN IBD PATIENTS - A HESSIAN COHORT
PROTEOMIC ANALYSES DO NOT REVEAL SUBCLINICAL INFLAMMATION IN FATIGUED PATIENTS WITH QUIESCENT INFLAMMATORY BOWEL DISEASE
THE UK INFLAMMATORY BOWEL DISEASE BIORESOURCE: PROGRESSING FROM GENETICS TO FUNCTION AND CLINICAL TRANSLATION IN CROHN'S DISEASE & ULCERATIVE COLITIS IN ADULTS, YOUNG PEOPLE AND CHILDREN
POTENTIAL OF HIGH-ACETATE PRODUCING SACCHAROMYCES BOULARDII TO ATTENUATE INFLAMMATION IN DSS-INDUCED COLITIS
TOLERANCE TO ADALIMUMAB CITRATE-FREE AND CITRATE FORMULATIONS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
TYPE I COLLAGEN DEGRADATION FRAGMENTS (C1M) AND HUMAN NEUTROPHIL ELASTASE-DERIVED FRAGMENTS OF CALPROTECTIN (CPA9-HNE) REFLECT BIOCHEMICAL AND ENDOSCOPIC DISEASE ACTIVITY IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES
USEFULNESS AND LIMITATIONS OF COMPUTER-AIDED DETECTION (CADE) SYSTEM IN SURVEILLANCE COLONOSCOPY IN PATIENTS WITH ULCERATIVE COLITIS
THE HEALTH DATA RESEARCH HUB FOR INFLAMMATORY BOWEL DISEASE - GUT REACTION- 3 YEARS ON
HIGHER ADALIMUMAB TROUGH LEVELS ARE ASSOCIATED WITH HISTOLOGIC REMISSION AND MUCOSAL HEALING
TOXIN GENE POLYMERASE CHAIN REACTION ASSAY FOR CLOSTRIDIOIDES DIFFICILE CAN BE AN INDICATOR SUGGESTING THE NEED FOR RAPID ESCALATION OF TREATMENT IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
PREDICTIVE MODEL FOR OUTCOMES IN INFLAMMATORY BOWEL DISEASE PATIENTS ON MAINTENANCE INFLIXIMAB THERAPY
EFFICACY AND SAFETY OF ADVANCED ORAL THERAPIES FOR THE TREATMENT OF INFLAMMATORY BOWEL DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS
A PHARMACIST-LED POST INDUCTION REVIEW CLINIC IMPROVES COMPLIANCE WITH KEY PERFORMANCE INDICATORS FOR PATIENTS NEWLY STARTED ON BIOLOGIC THERAPIES IN INFLAMMATORY BOWEL DISEASE
REAL WORLD EXPERIENCE OF USTEKINUMAB IN A WEST OF IRELAND COHORT
RENAL INVOLVEMENT IN A COHORT OF PAEDIATRIC PATIENTS WITH INFLAMMATORY BOWEL DISEASE
DETECTION OF IRON RESTRICTED ERYTHROPOIESIS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: OVERCOMING THE INFLAMMATION TANGLER
USE OF PLATELET-LYMPHOCYTE RATIO AND NEUTROPHIL-LYMPHOCYTE RATIO AS A POTENTIAL PROGNOSTIC MARKER IN IBD
IDENTIFICATION OF TARGET USTEKINUMAB LEVELS IN MAINTENANCE THERAPY IN INFLAMMATORY BOWEL DISEASE
Item 81 - 100 / 612
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
Chat with us
, powered by
LiveChat